FDA Warns Baxter Over Infusion Pump Quality Controls
The U.S. Food and Drug Administration on Tuesday revealed it had sent Baxter Healthcare Corp. a warning letter in December urging it to correct deficiencies with its elastomeric medicine infusion pump...To view the full article, register now.
Already a subscriber? Click here to view full article